BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25430005)

  • 1. Role of diffusion-weighted imaging, apparent diffusion coefficient and correlation with hepatobiliary phase findings in the differentiation of hepatocellular carcinoma from dysplastic nodules in cirrhotic liver.
    Inchingolo R; De Gaetano AM; Curione D; Ciresa M; Miele L; Pompili M; Vecchio FM; Giuliante F; Bonomo L
    Eur Radiol; 2015 Apr; 25(4):1087-96. PubMed ID: 25430005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
    Gatto A; De Gaetano AM; Giuga M; Ciresa M; Siciliani L; Miele L; Riccardi L; Pizzolante F; Rapaccini GL; Gasbarrini A; Giuliante F; Vecchio FM; Pompili M; Bonomo L
    Abdom Imaging; 2013 Aug; 38(4):736-44. PubMed ID: 22986351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
    Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Texture analysis of diffusion-weighted magnetic resonance imaging to identify atypically enhanced small hepatocellular carcinoma and dysplastic nodules under the background of cirrhosis].
    Zhong X; Li JS; Chen ZJ; Yin JX; Gui S; Sun ZQ; Tang HS
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):37-42. PubMed ID: 32023697
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.
    Shin SK; Kim YS; Choi SJ; Shim YS; Jung DH; Kwon OS; Choi DJ; Kim JH
    Medicine (Baltimore); 2017 Jul; 96(29):e7278. PubMed ID: 28723741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.
    Hwang J; Kim YK; Jeong WK; Choi D; Rhim H; Lee WJ
    Radiology; 2015 Jul; 276(1):137-46. PubMed ID: 25734551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
    Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
    Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging: Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.
    Li RK; Palmer SL; Zeng MS; Qiang JW; Chen F; Rao SX; Chen LL; Dai YM
    PLoS One; 2015; 10(11):e0142882. PubMed ID: 26605946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
    Earls JP; Theise ND; Weinreb JC; DeCorato DR; Krinsky GA; Rofsky NM; Mizrachi H; Teperman LW
    Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
    PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of diffusion-weighted imaging and gadoxetic acid-enhanced MR images in the evaluation of hepatocellular carcinoma and hypovascular hepatocellular nodules.
    Di Pietropaolo M; Briani C; Federici GF; Marignani M; Begini P; Delle Fave G; Iannicelli E
    Clin Imaging; 2015; 39(3):468-75. PubMed ID: 25748089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers.
    Bartolozzi C; Battaglia V; Bargellini I; Bozzi E; Campani D; Pollina LE; Filipponi F
    Abdom Imaging; 2013 Apr; 38(2):290-6. PubMed ID: 23053453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR features of regenerative nodules and dysplastic nodules in the cirrhotic liver.
    Xu H; Kong X; Xiong Y; Zhang X
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(5):601-3. PubMed ID: 16463687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade.
    Nasu K; Kuroki Y; Tsukamoto T; Nakajima H; Mori K; Minami M
    AJR Am J Roentgenol; 2009 Aug; 193(2):438-44. PubMed ID: 19620441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging of the liver in patients with chronic liver disease: comparison of monopolar and bipolar diffusion gradients for image quality and lesion detection.
    Lewis S; Kamath A; Chatterji M; Patel A; Shyknevsky I; Dyvorne HA; Kuehn B; Taouli B
    AJR Am J Roentgenol; 2015 Jan; 204(1):59-68. PubMed ID: 25539238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.